Lakmal Ranathunga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lakmal Ranathunga has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Asela Weerawardhana
College of Veterinary Medicine, Chungnam National University, DaeJeon, Republic of Korea
3 shared publications - Jong-Soo Lee
College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungnam National University, Yuseong-gu, Daejeon 34134, Republic of Korea
3 shared publications Barana Jayawardana
Affiliation Department of Animal Science, Faculty of Agriculture, University of Peradeniya, Peradeniya, Sri Lanka
2 shared publications- Kiramage Chathuranga
College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungnam National University, Yuseong-gu, Daejeon 34134, Republic of Korea
2 shared publications Nadeeka Nethmini
Affiliation School of Dentistry and Medical Science, Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW, Australia
2 shared publications- Niranjan Dodantenna
College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Food and Agriculture
- Vol. 12 (1) , 68-79
African Swine Fever in Sri Lanka: Emergence, Spread, and Current Control Strategies (2024 - 2025) - A Review
African swine fever (ASF) is a highly contagious viral disease that causes severe illness and high mortality in domestic pigs and wild boars. It spreads via direct contact with infected animals, contaminated feed, equipment, and soft tick vectors. First identified in East Africa in the early 20th century, ASF has spread globally, inflicting major economic losses on pig farming and threatening food security. The disease reached Asia in 2018 and Sri Lanka in late 2024, with initial cases in the Western and Northern Provinces rapidly expanding nationwide, leading to massive pig deaths and disrupted farming. Transmission in Sri Lanka stems mainly from unsafe practices such as swill feeding, poor biosecurity, and the movement of infected animals or materials. This narrative review synthesizes the available scientific evidence on the emergence, epidemiology, transmission dynamics, diagnosis, prevention, and control of African swine fever (ASF) in Sri Lanka from October 2024 to July 2025. A literature search was conducted using PubMed, Google Scholar, and institutional databases, including reports from the Food and Agriculture Organization (FAO), the World Organisation for Animal Health (WOAH), and the Department of Animal Production and Health (DAPH), using the search terms “African swine fever”, “ASF”, “Sri Lanka”, “epidemiology”, “transmission”, “diagnosis”, “biosecurity”, and “control”. This examines ASF's emergence and spread during 2024-2025, detailing transmission pathways and outbreak epidemiology. It assesses control measures; biosecurity improvements, surveillance, and containment, evaluating their success rates with supporting data. Sri Lanka’s Island epidemiology presents unique challenges, and this review fills a key knowledge gap on ASF dynamics in such settings. Enhanced biosecurity, farmer education, and research are vital to mitigate socioeconomic impacts on the pig sector. Coordinated national and international action is essential to control ASF and protect global pork production.
- 31 August 2026
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Food and Agriculture
- Vol. 12 (1) , 68-79
Open AccessAfrican Swine Fever in Sri Lanka: Emergence, Spread, and Current Control Strategies (2024 - 2025) - A Review
African swine fever (ASF) is a highly contagious viral disease that causes severe illness and high mortality in domestic pigs and wild boars. It spreads via direct contact with infected animals, contaminated feed, equipment, and soft tick vectors. First identified in East Africa in the early 20th century, ASF has spread globally, inflicting major economic losses on pig farming and threatening food security. The disease reached Asia in 2018 and Sri Lanka in late 2024, with initial cases in the Western and Northern Provinces rapidly expanding nationwide, leading to massive pig deaths and disrupted farming. Transmission in Sri Lanka stems mainly from unsafe practices such as swill feeding, poor biosecurity, and the movement of infected animals or materials. This narrative review synthesizes the available scientific evidence on the emergence, epidemiology, transmission dynamics, diagnosis, prevention, and control of African swine fever (ASF) in Sri Lanka from October 2024 to July 2025. A literature search was conducted using PubMed, Google Scholar, and institutional databases, including reports from the Food and Agriculture Organization (FAO), the World Organisation for Animal Health (WOAH), and the Department of Animal Production and Health (DAPH), using the search terms “African swine fever”, “ASF”, “Sri Lanka”, “epidemiology”, “transmission”, “diagnosis”, “biosecurity”, and “control”. This examines ASF's emergence and spread during 2024-2025, detailing transmission pathways and outbreak epidemiology. It assesses control measures; biosecurity improvements, surveillance, and containment, evaluating their success rates with supporting data. Sri Lanka’s Island epidemiology presents unique challenges, and this review fills a key knowledge gap on ASF dynamics in such settings. Enhanced biosecurity, farmer education, and research are vital to mitigate socioeconomic impacts on the pig sector. Coordinated national and international action is essential to control ASF and protect global pork production.
- Open Access
- 3 June 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (6) , e0341938
In silico pharmacological analysis of Tinospora cordifolia compounds targeting African swine fever virus B175L
African swine fever virus (ASFV) is a highly lethal DNA virus that suppresses the host’s immune response by establishing infection. B175L, one of its key immune-evasion proteins, directly inhibits STING-mediated type I interferon (IFN-I) signalling, thereby preventing the activation of antiviral defences. Thus, targeting B175L could be a promising strategy for antiviral drug development as effective ASFV inhibitors remain unidentified. In this study, we investigated the potential of Tinospora cordifolia ’s bioactive compounds to disrupt B175L’s function and restore immune signalling. Gas chromatography-mass spectrometry (GC-MS) analysis of the methanol extract from T. cordifolia stems identified 86 compounds. These were filtered using SwissADME, ProTox 3.0, and DataWarrior, yielding 15 compounds with favourable drug-likeness and safety profiles. We generated a highly accurate 3D model of ASFV B175L with strong confidence scores for the structural accuracy, using AlphaFold3. The filtered compounds were then subjected to virtual screening with PyRx 0.8, and the 3 compounds with binding affinities ≤ −6 kcal/mol were selected for subsequent analysis. Molecular dynamics (MD) simulations were used to assess binding stability, including root mean square deviation and fluctuation (RMSD, RMSF), protein-ligand contacts, radius of gyration (rGyr), and solvent accessible surface area (SASA) using Schrödinger Maestro. Taken together, these in silico results suggest that T. cordifolia- derived Benzaldehyde, 5-bromo-2-hydroxy-, (5-trifluoromethyl-2-pyridyl) hydrazone, Carbamic acid, N-(3-oxo-4-isoxazolidinyl)-, benzyl ester, and 1H-Indol-5-ol may act as potential inhibitors of B175L and represent preliminary antiviral hits against ASFV, warranting further in vitro and in vivo validation.
- 3 June 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (6) , e0341938
Open AccessIn silico pharmacological analysis of Tinospora cordifolia compounds targeting African swine fever virus B175L
African swine fever virus (ASFV) is a highly lethal DNA virus that suppresses the host’s immune response by establishing infection. B175L, one of its key immune-evasion proteins, directly inhibits STING-mediated type I interferon (IFN-I) signalling, thereby preventing the activation of antiviral defences. Thus, targeting B175L could be a promising strategy for antiviral drug development as effective ASFV inhibitors remain unidentified. In this study, we investigated the potential of Tinospora cordifolia ’s bioactive compounds to disrupt B175L’s function and restore immune signalling. Gas chromatography-mass spectrometry (GC-MS) analysis of the methanol extract from T. cordifolia stems identified 86 compounds. These were filtered using SwissADME, ProTox 3.0, and DataWarrior, yielding 15 compounds with favourable drug-likeness and safety profiles. We generated a highly accurate 3D model of ASFV B175L with strong confidence scores for the structural accuracy, using AlphaFold3. The filtered compounds were then subjected to virtual screening with PyRx 0.8, and the 3 compounds with binding affinities ≤ −6 kcal/mol were selected for subsequent analysis. Molecular dynamics (MD) simulations were used to assess binding stability, including root mean square deviation and fluctuation (RMSD, RMSF), protein-ligand contacts, radius of gyration (rGyr), and solvent accessible surface area (SASA) using Schrödinger Maestro. Taken together, these in silico results suggest that T. cordifolia- derived Benzaldehyde, 5-bromo-2-hydroxy-, (5-trifluoromethyl-2-pyridyl) hydrazone, Carbamic acid, N-(3-oxo-4-isoxazolidinyl)-, benzyl ester, and 1H-Indol-5-ol may act as potential inhibitors of B175L and represent preliminary antiviral hits against ASFV, warranting further in vitro and in vivo validation.
- Open Access
- 20 April 2026
- Published by Sri Lanka Journals Online in Sri Lankan Journal of Infectious Diseases
- Vol. 15, S16
In silico screening of Cyperus rotundus phytochemicals targeting African swine fever virus MGF 505-7R
- 20 April 2026
- Published by Sri Lanka Journals Online in Sri Lankan Journal of Infectious Diseases
- Vol. 15, S16
Open AccessIn silico screening of Cyperus rotundus phytochemicals targeting African swine fever virus MGF 505-7R
- Open Access
In silico pharmacological analysis of Tinospora cordifolia compounds targeting African swine fever virus B175L
African swine fever virus (ASFV) is a highly lethal DNA virus that suppresses the host’s immune response by establishing infection. B175L, one of its key immune evasion proteins, directly inhibits STING-mediated type I interferon (IFN-I) signaling, preventing antiviral defense activation. Thus, targeting B175L could be a promising strategy for antiviral drug development as effective ASFV inhibitors remain unidentified. In this study, we investigated the potential of the Tinospora cordifolia plant’s bioactive compounds to disrupt B175L’s function, restoring immune signaling. Gas chromatography-mass spectrometry (GC-MS) analysis of T. cordifolia stem’s methanol extract identified 124 compounds, of which 52 met SwissADME and DataWarrior criteria for drug-likeness and safety. We generated a highly accurate 3D B175L model with strong confidence scores for the structure accuracy, utilizing AlphaFold3. Virtual screening was performed using PyRx 0.8, and the top 4 ligands with binding affinities exceeding -6 kcal/mol advanced to CB-Dock2 and UCSF Chimera. Among them, Benzaldehyde, 5-bromo-2-hydroxy-, (5-trifluoromethyl-2pyridyl)hydrazone exhibited the highest binding affinity (-8.2 kcal/mol), confirming its strong interactions at the active site of B175L. Molecular dynamics (MD) simulations demonstrated the compound’s stability, with root mean square deviation and fluctuation (RMSD, RMSF) indicating minimal conformational changes (T. cordifolia- derived Benzaldehyde, 5-bromo-2-hydroxy-, (5-trifluoromethyl-2-pyridyl)hydrazone as a promising B175L inhibitor, advancing exploration towards effective antiviral solutions for ASFV.
Open AccessIn silico pharmacological analysis of Tinospora cordifolia compounds targeting African swine fever virus B175L
African swine fever virus (ASFV) is a highly lethal DNA virus that suppresses the host’s immune response by establishing infection. B175L, one of its key immune evasion proteins, directly inhibits STING-mediated type I interferon (IFN-I) signaling, preventing antiviral defense activation. Thus, targeting B175L could be a promising strategy for antiviral drug development as effective ASFV inhibitors remain unidentified. In this study, we investigated the potential of the Tinospora cordifolia plant’s bioactive compounds to disrupt B175L’s function, restoring immune signaling. Gas chromatography-mass spectrometry (GC-MS) analysis of T. cordifolia stem’s methanol extract identified 124 compounds, of which 52 met SwissADME and DataWarrior criteria for drug-likeness and safety. We generated a highly accurate 3D B175L model with strong confidence scores for the structure accuracy, utilizing AlphaFold3. Virtual screening was performed using PyRx 0.8, and the top 4 ligands with binding affinities exceeding -6 kcal/mol advanced to CB-Dock2 and UCSF Chimera. Among them, Benzaldehyde, 5-bromo-2-hydroxy-, (5-trifluoromethyl-2pyridyl)hydrazone exhibited the highest binding affinity (-8.2 kcal/mol), confirming its strong interactions at the active site of B175L. Molecular dynamics (MD) simulations demonstrated the compound’s stability, with root mean square deviation and fluctuation (RMSD, RMSF) indicating minimal conformational changes (T. cordifolia- derived Benzaldehyde, 5-bromo-2-hydroxy-, (5-trifluoromethyl-2-pyridyl)hydrazone as a promising B175L inhibitor, advancing exploration towards effective antiviral solutions for ASFV.
- Open Access
- 8 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2099
The African Swine Fever Virus Virulence Determinant DP96R Suppresses Type I IFN Production Targeting IRF3
DP96R of African swine fever virus (ASFV), also known as uridine kinase (UK), encodes a virulence-associated protein. Previous studies have examined DP96R along with other genes in an effort to create live attenuated vaccines. While experiments in pigs have explored the impact of DP96R on the pathogenicity of ASFV, the precise molecular mechanism underlying this phenomenon remains unknown. Here, we describe a novel molecular mechanism by which DP96R suppresses interferon regulator factor-3 (IRF3)-mediated antiviral immune responses. DP96R interacts with a crucial karyopherin (KPNA) binding site within IRF3, disrupting the KPNA-IRF3 interaction and consequently impeding the translocation of IRF3 to the nucleus. Under this mechanistic basis, the ectopic expression of DP96R enhances the replication of DNA and RNA viruses by inhibiting the production of IFNs, whereas DP96R knock-down resulted in higher IFNs and IFN-stimulated gene (ISG) transcription during ASFV infection. Collectively, these findings underscore the pivotal role of DP96R in inhibiting IFN responses and increase our understanding of the relationship between DP96R and the virulence of ASFV.
- 8 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2099
Open AccessThe African Swine Fever Virus Virulence Determinant DP96R Suppresses Type I IFN Production Targeting IRF3
DP96R of African swine fever virus (ASFV), also known as uridine kinase (UK), encodes a virulence-associated protein. Previous studies have examined DP96R along with other genes in an effort to create live attenuated vaccines. While experiments in pigs have explored the impact of DP96R on the pathogenicity of ASFV, the precise molecular mechanism underlying this phenomenon remains unknown. Here, we describe a novel molecular mechanism by which DP96R suppresses interferon regulator factor-3 (IRF3)-mediated antiviral immune responses. DP96R interacts with a crucial karyopherin (KPNA) binding site within IRF3, disrupting the KPNA-IRF3 interaction and consequently impeding the translocation of IRF3 to the nucleus. Under this mechanistic basis, the ectopic expression of DP96R enhances the replication of DNA and RNA viruses by inhibiting the production of IFNs, whereas DP96R knock-down resulted in higher IFNs and IFN-stimulated gene (ISG) transcription during ASFV infection. Collectively, these findings underscore the pivotal role of DP96R in inhibiting IFN responses and increase our understanding of the relationship between DP96R and the virulence of ASFV.
- RetractedOpen Access
- 30 November 2023
- Published by American Society for Microbiology in Journal of Virology
- Vol. 97 (11) , e0079523
RETRACTED: African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2′3′-cGAMP
Type I interferon (IFN)-mediated responses operate a pivotal role in the first line of host immune defense against viruses. Upon DNA virus infection, DNA sensing cyclic GMP-AMP synthase-STING signal pathway is a key event in the IFN-mediated antiviral response and also a target of viral immune evasion. African swine fever (ASF) is a highly contagious, cross-border viral disease that often confers fatalities in domestic and feral pigs of all ages. African swine fever virus (ASFV), a causative agent of ASF, is a nucleocytoplasmic large DNA virus that masks critical elements of host immune system by several encoded proteins. In this study, we report a novel immune evasion mechanism of ASFV B175L to block type I IFN signaling by targeting STING and 2'3'-cyclic GMP-AMP (2′3′-cGAMP). We found that ASFV B175L significantly inhibited the DNA virus-induced IFN-β production and IFN-mediated signaling responses. The conserved zf-FCS motif of ASFV B175L competitively interacted with both cGAMP and the cyclic dinucleotide binding domain of STING. Remarkably, the R238 and Y240 amino acids of STING were crucial for interaction with ASFV B175L. Consequently, this interaction inhibits the interaction between cGAMP and STING, thereby inhibiting downstream signaling including STING polymerization and phosphorylation of TANK-binding kinase 1 and interferon regulatory factor 3 for antiviral signaling. Taken together, these results highlight the critical role of ASFV B175L in suppression of IFN responses and provide a new target to guide live-attenuated ASFV vaccine. IMPORTANCE: African swine fever virus (ASFV), the only known DNA arbovirus, is the causative agent of African swine fever (ASF), an acutely contagious disease in pigs. ASF has recently become a crisis in the pig industry in recent years, but there are no commercially available vaccines. Studying the immune evasion mechanisms of ASFV proteins is important for the understanding the pathogenesis of ASFV and essential information for the development of an effective live-attenuated ASFV vaccines. Here, we identified ASFV B175L, previously uncharacterized proteins that inhibit type I interferon signaling by targeting STING and 2′3′-cGAMP. The conserved B175L-zf-FCS motif specifically interacted with both cGAMP and the R238 and Y240 amino acids of STING. Consequently, this interaction interferes with the interaction of cGAMP and STING, thereby inhibiting downstream signaling of IFN-mediated antiviral responses. This novel mechanism of B175L opens a new avenue as one of the ASFV virulent genes that can contribute to the advancement of ASFV live-attenuated vaccines.
- 30 November 2023
- Published by American Society for Microbiology in Journal of Virology
- Vol. 97 (11) , e0079523
RetractedOpen AccessRETRACTED: African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2′3′-cGAMP
Type I interferon (IFN)-mediated responses operate a pivotal role in the first line of host immune defense against viruses. Upon DNA virus infection, DNA sensing cyclic GMP-AMP synthase-STING signal pathway is a key event in the IFN-mediated antiviral response and also a target of viral immune evasion. African swine fever (ASF) is a highly contagious, cross-border viral disease that often confers fatalities in domestic and feral pigs of all ages. African swine fever virus (ASFV), a causative agent of ASF, is a nucleocytoplasmic large DNA virus that masks critical elements of host immune system by several encoded proteins. In this study, we report a novel immune evasion mechanism of ASFV B175L to block type I IFN signaling by targeting STING and 2'3'-cyclic GMP-AMP (2′3′-cGAMP). We found that ASFV B175L significantly inhibited the DNA virus-induced IFN-β production and IFN-mediated signaling responses. The conserved zf-FCS motif of ASFV B175L competitively interacted with both cGAMP and the cyclic dinucleotide binding domain of STING. Remarkably, the R238 and Y240 amino acids of STING were crucial for interaction with ASFV B175L. Consequently, this interaction inhibits the interaction between cGAMP and STING, thereby inhibiting downstream signaling including STING polymerization and phosphorylation of TANK-binding kinase 1 and interferon regulatory factor 3 for antiviral signaling. Taken together, these results highlight the critical role of ASFV B175L in suppression of IFN responses and provide a new target to guide live-attenuated ASFV vaccine. IMPORTANCE: African swine fever virus (ASFV), the only known DNA arbovirus, is the causative agent of African swine fever (ASF), an acutely contagious disease in pigs. ASF has recently become a crisis in the pig industry in recent years, but there are no commercially available vaccines. Studying the immune evasion mechanisms of ASFV proteins is important for the understanding the pathogenesis of ASFV and essential information for the development of an effective live-attenuated ASFV vaccines. Here, we identified ASFV B175L, previously uncharacterized proteins that inhibit type I interferon signaling by targeting STING and 2′3′-cGAMP. The conserved B175L-zf-FCS motif specifically interacted with both cGAMP and the R238 and Y240 amino acids of STING. Consequently, this interaction interferes with the interaction of cGAMP and STING, thereby inhibiting downstream signaling of IFN-mediated antiviral responses. This novel mechanism of B175L opens a new avenue as one of the ASFV virulent genes that can contribute to the advancement of ASFV live-attenuated vaccines.
- Open Access
Inhibitory Effect of Sargassum fusiforme and Its Components on Replication of Respiratory Syncytial Virus In Vitro and In Vivo
Sargassum fusiforme, a plant used as a medicine and food, is regarded as a marine vegetable and health supplement to improve life expectancy. Here, we demonstrate that S. fusiforme extract (SFE) has antiviral effects against respiratory syncytial virus (RSV) in vitro and in vivo mouse model. Treatment of HEp2 cells with a non-cytotoxic concentration of SFE significantly reduced RSV replication, RSV-induced cell death, RSV gene transcription, RSV protein synthesis, and syncytium formation. Moreover, oral inoculation of SFE significantly improved RSV clearance from the lungs of BALB/c mice. Interestingly, the phenolic compounds eicosane, docosane, and tetracosane were identified as active components of SFE. Treatment with a non-cytotoxic concentration of these three components elicited similar antiviral effects against RSV infection as SFE in vitro. Together, these results suggest that SFE and its potential components are a promising natural antiviral agent candidate against RSV infection.
Open AccessInhibitory Effect of Sargassum fusiforme and Its Components on Replication of Respiratory Syncytial Virus In Vitro and In Vivo
Sargassum fusiforme, a plant used as a medicine and food, is regarded as a marine vegetable and health supplement to improve life expectancy. Here, we demonstrate that S. fusiforme extract (SFE) has antiviral effects against respiratory syncytial virus (RSV) in vitro and in vivo mouse model. Treatment of HEp2 cells with a non-cytotoxic concentration of SFE significantly reduced RSV replication, RSV-induced cell death, RSV gene transcription, RSV protein synthesis, and syncytium formation. Moreover, oral inoculation of SFE significantly improved RSV clearance from the lungs of BALB/c mice. Interestingly, the phenolic compounds eicosane, docosane, and tetracosane were identified as active components of SFE. Treatment with a non-cytotoxic concentration of these three components elicited similar antiviral effects against RSV infection as SFE in vitro. Together, these results suggest that SFE and its potential components are a promising natural antiviral agent candidate against RSV infection.